Resources

This issue of Outlook examines the scope and impact of misperceptions about contraception, the science behind debunking misperceptions, and approaches that programs are using to address this persistent problem.Outlook, June 2015.

Despite significant gains in global health in the past several decades, too many people still die every year from preventable and treatable diseases and conditions. To continue our progress toward a healthier world, new and better health tools and technologies are urgently needed. Ongoing investment in global health research and development (R&D) is essential to advance promising tools and make them available, particularly among the poorest and most marginalized. This fact sheet highlights PATH’s efforts to accelerate lifesaving innovations and strengthen policies to advance global health R&D.

The SILCS diaphragm has been evaluated in ten studies conducted in multiple countries since 1998. These studies include design validation and consumer use studies, as well as clinical studies of safety, effectiveness, and acceptability. This document provides summaries of the key studies implemented during development and validation of SILCS as a barrier contraceptive.

This fact sheet provides an overview of PATH's work in protecting children from diarrheal disease.

This report presents the results from a stakeholder analysis conducted in Ethiopia by the PATH Malaria Control and Elimination Partnership in Africa (MACEPA) in partnership with Ethiopia’s Federal Ministry of Health (FMOH). The stakeholder analysis was designed to assess the perceptions of key stakeholders in malaria policy and implementation decision-making around readiness to introduce and scale new tools and approaches to accelerate efforts toward malaria elimination. The analysis also assessed perceptions around what respondents felt was needed to accelerate progress toward national targets and opportunities and barriers to increasing the prominence of malaria on the national health agenda.